VCRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Vicore Pharma Holding AB
$8.85−0.13 (-1.45%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Vicore Pharma Holding AB.